Android app Apple app link

Biogen Inc. (BIIB) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$123.73

south_east
-$6.98 (-5.34%)
Day's range
$123.02
Day's range
$129.95

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
02/13/2025 Canaccord Genuity Sumant Kulkarni $265.00 $138.06   91.95%
02/12/2025 Needham Ami Fadia $270.00 $133.43   102.35%
02/12/2025 Wells Fargo Mohit Bansal $165.00 $133.43   23.66%
02/12/2025 Citigroup Geoff Meacham $160.00 $133.43   19.91%
12/09/2024 Jefferies Michael Yee $180.00 $157.78   14.08%
11/15/2024 Robert W. Baird Brian Skorney $300.00 $162.83   84.24%
10/31/2024 Oppenheimer Jay Olson $255.00 $181.18   40.74%
10/31/2024 Morgan Stanley Terence Flynn $204.00 $181.18   12.6%
10/30/2024 Raymond James Christopher Raymond $315.00 $181.18   73.86%
10/30/2024 Goldman Sachs Salveen Richter $290.00 $181.18   60.06%
10/17/2024 BMO Capital Evan Seigerman $230.00 $188.17   22.23%
10/03/2024 UBS Ashwani Verma $202.00 $188.74   7.03%
09/23/2024 Wedbush Laura Chico $205.00 $199.36   2.83%
07/29/2024 Robert W. Baird Brian Skorney $294.00 $212.70   38.22%
07/26/2024 Goldman Sachs Salveen Richter $342.00 $211.17   61.95%
07/26/2024 Piper Sandler Christopher Raymond $307.00 $211.17   45.38%
07/26/2024 RBC Capital Brian Abrahams $282.00 $214.16   31.68%
07/12/2024 Piper Sandler Christopher Raymond $313.00 $236.80   32.18%
07/11/2024 Morgan Stanley Terence Flynn $311.00 $232.75   33.62%
06/12/2024 Scotiabank George Farmer $275.00 $230.28   19.42%
05/23/2024 BMO Capital Evan David Seigerman $260.00 $220.00   18.18%
05/22/2024 Stifel Nicolaus Paul Matteis $275.00 $225.21   22.11%
05/22/2024 Raymond James Christopher Raymond $335.00 $225.21   48.75%
05/22/2024 Morgan Stanley Matthew Harrison $331.00 $224.48   47.45%
04/25/2024 Wedbush Laura Chico $215.00 $204.65   5.06%
04/25/2024 H.C. Wainwright Andrew Fein $300.00 $201.99   48.52%
04/25/2024 RBC Capital Brian Abrahams $317.00 $201.99   56.94%
04/19/2024 Oppenheimer Jay Olson $270.00 $190.52   41.72%
04/03/2024 Barclays Carter Gould $215.00 $206.38   4.18%
08/07/2023 Wedbush Laura Chico $269.00 $271.23   -0.82%
05/01/2023 Guggenheim Yatin Suneja $350.00 $311.11   12.5%
09/28/2022 Atlantic Equities Steve Chesney $200.00 $271.17   -26.24%
09/28/2022 Needham Ami Fadia $250.00 $271.17   -7.81%
09/28/2022 Morgan Stanley Matthew Harrison $285.00 $271.14   5.11%
09/28/2022 BMO Capital Evan David Seigerman $360.00 $197.79   82.01%
09/28/2022 Mizuho Securities Salim Syed $270.00 $197.79   36.51%
09/27/2022 Needham Ami Fadia $250.00 $197.79   26.4%
09/27/2022 Robert W. Baird Brian Skorney $340.00 $197.79   71.9%
04/18/2022 Wells Fargo Mohit Bansal $265.00 $212.55   24.68%
04/06/2022 Robert W. Baird Brian Skorney $224.00 $211.64   5.84%
04/06/2022 Jefferies Michael Yee $300.00 $211.64   41.75%
04/06/2022 Piper Sandler Christopher Raymond $200.00 $211.64   -5.5%
04/04/2022 RBC Capital Brian Abrahams $244.00 $207.61   17.53%
03/27/2022 Bank of America Securities Geoff Meacham $225.00 $211.68   6.29%
03/14/2022 BMO Capital Evan Seigerman $238.00 $197.36   20.59%
02/27/2022 Canaccord Genuity Sumant Kulkarni $285.00 $211.01   35.06%
02/21/2022 Guggenheim Yatin Suneja $200.00 $209.81   -4.68%
02/15/2022 Truist Financial Robyn Karnauskas $320.00 $214.55   49.15%
02/06/2022 Mizuho Securities Salim Syed $207.00 $221.30   -6.46%
02/03/2022 Barclays Carter Gould $235.00 $221.53   6.08%
02/03/2022 Wells Fargo Mohit Bansal $235.00 $221.53   6.08%
02/03/2022 Wolfe Research Tim Anderson $217.00 $221.53   -2.04%
02/03/2022 Morgan Stanley Matthew Harrison $330.00 $221.53   48.96%
02/03/2022 Cowen & Co. Phil Nadeau $285.00 $221.53   28.65%
02/02/2022 J.P. Morgan Cory Kasimov $236.00 $220.17   7.19%
01/11/2022 Cantor Fitzgerald Alethia Young $209.00 $225.34   -7.25%
01/02/2022 Bernstein Aaron Gal $400.00 $244.14   63.84%
12/05/2021 Goldman Sachs Salveen Richter $271.00 $224.11   20.92%
10/19/2021 UBS Colin Bristow $405.00 $266.57   51.93%
06/07/2021 Atlantic Equities Steve Chesney $415.00 $395.37   4.96%

Biogen Inc. FAQ's

Biogen Inc. has been rated by research analysts at Canaccord Genuity, Needham, Wells Fargo, Citigroup, Jefferies, Robert W. Baird in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.